SB
SAB Biotherapeutics Inc
🇺🇸XNAS.SABSUnited StatesHealthcare
$3.39USDdown -0.03 (-0.88%)ClosedEnd of day7:42 AM
Price$3.39-0.03 (-0.88%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US78397T2024
- CUSIP
- 78397T103
Company
- Employees
- 86
- Headquarters
- Miami Beach, United States
- Website
- https://www.sab.bio
- CEO
- Mr. Samuel J. Reich
Market
- Shares outstanding
- 91M
- Market cap
- $308.44M
Highlights
- Market cap
- $308.44M
- EPS LTM
- -$0.14calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -24.14calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$12.78M+65.52%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$72.7M-137.04%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.